메뉴 건너뛰기
Kidney International
Volumn 68, Issue 3, 2005, Pages 1364-1365
Racial and ethnic disparities in renal disease
Author keywords

Chronic kidney disease; Developing world; Diabetes; Hypertension; Renal replacement therapy
Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
EID: 32644478601     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00545.x     Document Type: Editorial
Times cited : (4)
References (10)
  • 1
    • 0017620708 scopus 로고
    • Racial factors in the incidence and causation of end stage renal disease (ESRD)
    • EASTERLING RE: Racial factors in the incidence and causation of end stage renal disease (ESRD). Trans Amer Soc Art Intern Org 23:28-33, 1977
    • (1977) Trans Amer Soc Art Intern Org , vol.23 , pp. 28-33
    • Easterling, R.E.1
  • 2
    • 32644464443 scopus 로고    scopus 로고
    • Unraveling the racial disparities associated with kidney disease
    • NORRIS KC, AGODOA LY: Unraveling the racial disparities associated with kidney disease. Kidney Int 68:914-924, 2005
    • (2005) Kidney Int , vol.68 , pp. 914-924
    • Norris, K.C.1    Agodoa, L.Y.2
  • 3
    • 24944441830 scopus 로고    scopus 로고
    • Ethnicity and renal disease
    • FEEHALLY J: Ethnicity and renal disease. Kidney Int 68:414-424, 2005
    • (2005) Kidney Int , vol.68 , pp. 414-424
    • Feehally, J.1
  • 4
    • 0345735907 scopus 로고    scopus 로고
    • Exploring the pathways from disadvantage to end-stage renal disease for indigenous Australians
    • CASS A, CUNNINGHAM J, SNELLING P, et al: Exploring the pathways from disadvantage to end-stage renal disease for indigenous Australians. Soc Sci Med 58:767-785, 2004
    • (2004) Soc Sci Med , vol.58 , pp. 767-785
    • Cass, A.1    Cunningham, J.2    Snelling, P.3
  • 5
    • 3543059330 scopus 로고    scopus 로고
    • Will racial and ethnic disparities in health be resolved primarily outside of standard medical care
    • PINCUS T: Will racial and ethnic disparities in health be resolved primarily outside of standard medical care. Ann Intern Med 141:224-225, 2004
    • (2004) Ann Intern Med , vol.141 , pp. 224-225
    • Pincus, T.1
  • 6
    • 3142779938 scopus 로고    scopus 로고
    • The incidence of endstage renal disease is increasing faster than the prevalence of chronic renal insufficiency
    • HSU CY, VITTINGHOF E, LIN F, SHLIPAK M: The incidence of endstage renal disease is increasing faster than the prevalence of chronic renal insufficiency. Ann Intern Med 141: 95-101, 2004
    • (2004) Ann Intern Med , vol.141 , pp. 95-101
    • Hsu, C.Y.1    Vittinghof, E.2    Lin, F.3    Shlipak, M.4
  • 7
    • 0037248897 scopus 로고    scopus 로고
    • Prevention of chronic renal failure at the community level
    • MANI MK: Prevention of chronic renal failure at the community level. Kidney Int (Suppl 83):S86-89, 2003
    • (2003) Kidney Int , Issue.83 SUPPL.
    • Mani, M.K.1
  • 8
    • 0027517659 scopus 로고
    • The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy
    • LEWIS EJ, HUNSICKER LJ, BAIN RP, ROHDE RP: The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. N Engl J Med 329:1456-1462, 1993
    • (1993) N Engl J Med , vol.329 , pp. 1456-1462
    • Lewis, E.J.1    Hunsicker, L.J.2    Bain, R.P.3    Rohde, R.P.4
  • 9
    • 0012832737 scopus 로고    scopus 로고
    • Secondary prevention of renal and cardiovascular disease. Results of a renal and cardiovascular program in an Australian aboriginal community
    • HOY WE, WANG Z, BAKER PR, KELLY AM: Secondary prevention of renal and cardiovascular disease. Results of a renal and cardiovascular program in an Australian aboriginal community. J Am Soc Nephrol 14(Suppl 2):S178-185, 2003
    • (2003) J Am Soc Nephrol , vol.14 , Issue.2 SUPPL.
    • Hoy, W.E.1    Wang, Z.2    Baker, P.R.3    Kelly, A.M.4
  • 10
    • 0037145856 scopus 로고    scopus 로고
    • Effect of blood pressure lowering and hypertensive drug class on the progression of hypertensive kidney disease. Results from the AASK trial
    • WRIGHT JT, JR., BAKRIS G, GREENE T, et al: Effect of blood pressure lowering and hypertensive drug class on the progression of hypertensive kidney disease. Results from the AASK trial. JAMA 288:2421-2431, 2002
    • (2002) JAMA , vol.288 , pp. 2421-2431
    • Wright Jr., J.T.1    Bakris, G.2    Greene, T.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.